Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11878987 Heterocyclic compound as TRK inhibitor

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Chao Zhou0

Zhixiang Zheng0

Norman Xianglong Kong0

Date of Patent

January 23, 2024

0

Patent Application Number

172557970

Date Filed

June 25, 2019

0

Patent Citations

US Patent 9493476 Macrocyclic compounds as trk kinase inhibitors

0

US Patent 9676783 Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compounds

0

US Patent 9718822 Macrocyclic compounds as Trk kinase inhibitors

0

US Patent 9840519 Macrocyclic compounds as TRK kinase inhibitors

0

US Patent 9750744 Macrocyclic compounds as Trk kinase inhibitors

0

US Patent 9902741 Macrocyclic compounds as TRK kinase inhibitors

0

US Patent 8933084 Macrocyclic compounds as Trk kinase inhibitors

0

US Patent 9447104 Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds

0

Patent Primary Examiner

Timothy R Rozof

0

CPC Code

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11878987 Heterocyclic compound as TRK inhibitor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool